Trials / Conditions / Atypical Meningioma
Atypical Meningioma
5 registered clinical trials studyying Atypical Meningioma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | Study of the Inflammatory Microenvironment in Atypical Meningiomas NCT04761653 | Central Hospital, Nancy, France | — |
| Recruiting | Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms NCT04541082 | Jazz Pharmaceuticals | Phase 1 |
| Unknown | Oncological Care for Patients With Meningioma NCT02973256 | University Hospital, Montpellier | — |
| Terminated | A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma NCT03016091 | Rabin Medical Center | Phase 2 |
| Recruiting | Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Gra NCT02847559 | Northwestern University | Phase 2 |